| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC128 | |||||||||||||||||||||||
| Submitter : | Dr. Wieke Liem | Date & Time: | 12/07/2006 11:12:32 | |||||||||||||||||||||
| Organization : | Dr. Wieke Liem | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Hydroquinone is one of the most effective agents in treating hyperpigmentation, used over 50 yrs in millions of people. It is used to treat melasma, psot-inflammatory hyperpigmentation, and medically and cosmetically disfiguring dyschromias.
Since 1961, hydroquinone has a very safe and effective treatment profile. In spite of human exposure to natural sources of hydroquinone in wheat, pears, berries, coffee, tea, onions, rice and red wine, there is not an association with carcinogenicity. There have been no reported cases of related cancers in more than 50 yrs of use of hydroquinone. | ||||||||||||||||||||||||